nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclopentolate—BCHE—breast cancer	0.407	1	CbGaD
Cyclopentolate—Bromodiphenhydramine—Toremifene—breast cancer	0.114	0.247	CrCrCtD
Cyclopentolate—Orphenadrine—Toremifene—breast cancer	0.0897	0.194	CrCrCtD
Cyclopentolate—Diphenhydramine—Toremifene—breast cancer	0.0797	0.173	CrCrCtD
Cyclopentolate—Bromodiphenhydramine—Tamoxifen—breast cancer	0.0717	0.155	CrCrCtD
Cyclopentolate—Orphenadrine—Tamoxifen—breast cancer	0.0563	0.122	CrCrCtD
Cyclopentolate—Diphenhydramine—Tamoxifen—breast cancer	0.05	0.108	CrCrCtD
Cyclopentolate—CHRM3—muscle of abdomen—breast cancer	0.00542	0.417	CbGeAlD
Cyclopentolate—Vasodilation procedure—Fulvestrant—breast cancer	0.00164	0.0209	CcSEcCtD
Cyclopentolate—Vasodilation—Fulvestrant—breast cancer	0.00164	0.0209	CcSEcCtD
Cyclopentolate—Coordination abnormal—Toremifene—breast cancer	0.00145	0.0185	CcSEcCtD
Cyclopentolate—Punctate keratitis—Capecitabine—breast cancer	0.00142	0.0181	CcSEcCtD
Cyclopentolate—Lacrimation increased—Ixabepilone—breast cancer	0.00128	0.0163	CcSEcCtD
Cyclopentolate—Vasodilation—Anastrozole—breast cancer	0.00126	0.0161	CcSEcCtD
Cyclopentolate—Vasodilation procedure—Anastrozole—breast cancer	0.00126	0.0161	CcSEcCtD
Cyclopentolate—Coordination abnormal—Ixabepilone—breast cancer	0.0012	0.0153	CcSEcCtD
Cyclopentolate—Vasodilation procedure—Raloxifene—breast cancer	0.0012	0.0153	CcSEcCtD
Cyclopentolate—Vasodilation—Raloxifene—breast cancer	0.0012	0.0153	CcSEcCtD
Cyclopentolate—Hyperpyrexia—Paclitaxel—breast cancer	0.00117	0.015	CcSEcCtD
Cyclopentolate—Paralysis—Tamoxifen—breast cancer	0.00109	0.014	CcSEcCtD
Cyclopentolate—Ataxia—Toremifene—breast cancer	0.00097	0.0124	CcSEcCtD
Cyclopentolate—Lacrimation—Irinotecan—breast cancer	0.000912	0.0116	CcSEcCtD
Cyclopentolate—Lacrimation—Fluorouracil—breast cancer	0.000874	0.0111	CcSEcCtD
Cyclopentolate—Gastroenteritis—Raloxifene—breast cancer	0.000864	0.011	CcSEcCtD
Cyclopentolate—Vasodilation—Goserelin—breast cancer	0.000827	0.0105	CcSEcCtD
Cyclopentolate—Vasodilation procedure—Goserelin—breast cancer	0.000827	0.0105	CcSEcCtD
Cyclopentolate—BCHE—nipple—breast cancer	0.000782	0.0602	CbGeAlD
Cyclopentolate—Vasodilation procedure—Vinorelbine—breast cancer	0.00074	0.00944	CcSEcCtD
Cyclopentolate—Vasodilation—Vinorelbine—breast cancer	0.00074	0.00944	CcSEcCtD
Cyclopentolate—Photophobia—Vinblastine—breast cancer	0.000735	0.00937	CcSEcCtD
Cyclopentolate—Lacrimation—Docetaxel—breast cancer	0.000631	0.00804	CcSEcCtD
Cyclopentolate—Vasodilation—Irinotecan—breast cancer	0.000611	0.00779	CcSEcCtD
Cyclopentolate—Vasodilation procedure—Irinotecan—breast cancer	0.000611	0.00779	CcSEcCtD
Cyclopentolate—Vision blurred—Toremifene—breast cancer	0.000585	0.00747	CcSEcCtD
Cyclopentolate—Photophobia—Thiotepa—breast cancer	0.000583	0.00744	CcSEcCtD
Cyclopentolate—Ataxia—Chlorambucil—breast cancer	0.000583	0.00743	CcSEcCtD
Cyclopentolate—Lacrimation increased—Irinotecan—breast cancer	0.000582	0.00742	CcSEcCtD
Cyclopentolate—Tremor—Toremifene—breast cancer	0.000582	0.00742	CcSEcCtD
Cyclopentolate—Conjunctivitis—Raloxifene—breast cancer	0.000573	0.00731	CcSEcCtD
Cyclopentolate—Vertigo—Fulvestrant—breast cancer	0.000565	0.00721	CcSEcCtD
Cyclopentolate—Vertigo—Toremifene—breast cancer	0.000558	0.00712	CcSEcCtD
Cyclopentolate—Lacrimation increased—Fluorouracil—breast cancer	0.000558	0.00711	CcSEcCtD
Cyclopentolate—CHRM1—female reproductive system—breast cancer	0.000535	0.0412	CbGeAlD
Cyclopentolate—CHRM3—adipose tissue—breast cancer	0.000521	0.0401	CbGeAlD
Cyclopentolate—Flushing—Letrozole—breast cancer	0.000518	0.0066	CcSEcCtD
Cyclopentolate—Psychotic disorder—Goserelin—breast cancer	0.000515	0.00657	CcSEcCtD
Cyclopentolate—Urinary retention—Goserelin—breast cancer	0.000501	0.00639	CcSEcCtD
Cyclopentolate—BCHE—skin of body—breast cancer	0.000501	0.0385	CbGeAlD
Cyclopentolate—Flushing—Idarubicin—breast cancer	0.000492	0.00627	CcSEcCtD
Cyclopentolate—Flushing—Raloxifene—breast cancer	0.000492	0.00627	CcSEcCtD
Cyclopentolate—Photophobia—Fluorouracil—breast cancer	0.000482	0.00615	CcSEcCtD
Cyclopentolate—CHRM3—female reproductive system—breast cancer	0.000479	0.0369	CbGeAlD
Cyclopentolate—Lacrimation increased—Paclitaxel—breast cancer	0.000475	0.00605	CcSEcCtD
Cyclopentolate—BCHE—endometrium—breast cancer	0.000472	0.0363	CbGeAlD
Cyclopentolate—Coma—Fluorouracil—breast cancer	0.000469	0.00599	CcSEcCtD
Cyclopentolate—Venlafaxine—ABCG2—breast cancer	0.000458	0.153	CrCbGaD
Cyclopentolate—Vision blurred—Letrozole—breast cancer	0.000458	0.00584	CcSEcCtD
Cyclopentolate—Desvenlafaxine—CYP3A4—breast cancer	0.000453	0.151	CrCbGaD
Cyclopentolate—CHRM1—endocrine gland—breast cancer	0.000453	0.0349	CbGeAlD
Cyclopentolate—Vertigo—Letrozole—breast cancer	0.000436	0.00557	CcSEcCtD
Cyclopentolate—CHRM3—female gonad—breast cancer	0.000436	0.0336	CbGeAlD
Cyclopentolate—BCHE—uterus—breast cancer	0.000435	0.0335	CbGeAlD
Cyclopentolate—Urinary retention—Thiotepa—breast cancer	0.000429	0.00547	CcSEcCtD
Cyclopentolate—BCHE—pituitary gland—breast cancer	0.000427	0.0329	CbGeAlD
Cyclopentolate—Hallucination—Chlorambucil—breast cancer	0.000427	0.00544	CcSEcCtD
Cyclopentolate—Lacrimation—Epirubicin—breast cancer	0.000425	0.00542	CcSEcCtD
Cyclopentolate—BCHE—adipose tissue—breast cancer	0.000425	0.0327	CbGeAlD
Cyclopentolate—Ataxia—Thiotepa—breast cancer	0.000424	0.00541	CcSEcCtD
Cyclopentolate—Disorientation—Fluorouracil—breast cancer	0.000417	0.00532	CcSEcCtD
Cyclopentolate—Vertigo—Raloxifene—breast cancer	0.000414	0.00528	CcSEcCtD
Cyclopentolate—Drowsiness—Goserelin—breast cancer	0.000406	0.00518	CcSEcCtD
Cyclopentolate—CHRM3—endocrine gland—breast cancer	0.000405	0.0312	CbGeAlD
Cyclopentolate—Dry mouth—Letrozole—breast cancer	0.000404	0.00516	CcSEcCtD
Cyclopentolate—Dry mouth—Anastrozole—breast cancer	0.000404	0.00516	CcSEcCtD
Cyclopentolate—Lacrimation increased—Docetaxel—breast cancer	0.000402	0.00513	CcSEcCtD
Cyclopentolate—Convulsion—Idarubicin—breast cancer	0.000399	0.00509	CcSEcCtD
Cyclopentolate—Pruritus—Lapatinib—breast cancer	0.000395	0.00504	CcSEcCtD
Cyclopentolate—Lacrimation—Doxorubicin—breast cancer	0.000394	0.00502	CcSEcCtD
Cyclopentolate—BCHE—female reproductive system—breast cancer	0.000391	0.0301	CbGeAlD
Cyclopentolate—Lacrimation increased—Capecitabine—breast cancer	0.00039	0.00497	CcSEcCtD
Cyclopentolate—Tachycardia—Letrozole—breast cancer	0.000387	0.00493	CcSEcCtD
Cyclopentolate—Paralysis—Methotrexate—breast cancer	0.000385	0.00491	CcSEcCtD
Cyclopentolate—BCHE—adrenal gland—breast cancer	0.000382	0.0294	CbGeAlD
Cyclopentolate—BCHE—bone marrow—breast cancer	0.000369	0.0284	CbGeAlD
Cyclopentolate—Coordination abnormal—Capecitabine—breast cancer	0.000366	0.00466	CcSEcCtD
Cyclopentolate—Pruritus—Fulvestrant—breast cancer	0.000363	0.00463	CcSEcCtD
Cyclopentolate—Paralysis—Epirubicin—breast cancer	0.00036	0.00459	CcSEcCtD
Cyclopentolate—Pruritus—Toremifene—breast cancer	0.000359	0.00457	CcSEcCtD
Cyclopentolate—Flushing—Tamoxifen—breast cancer	0.000354	0.00452	CcSEcCtD
Cyclopentolate—Somnolence—Letrozole—breast cancer	0.000352	0.00449	CcSEcCtD
Cyclopentolate—Somnolence—Anastrozole—breast cancer	0.000352	0.00449	CcSEcCtD
Cyclopentolate—Rash—Lapatinib—breast cancer	0.000352	0.00449	CcSEcCtD
Cyclopentolate—Dermatitis—Lapatinib—breast cancer	0.000352	0.00449	CcSEcCtD
Cyclopentolate—Ataxia—Fluorouracil—breast cancer	0.000351	0.00447	CcSEcCtD
Cyclopentolate—Tremor—Chlorambucil—breast cancer	0.00035	0.00446	CcSEcCtD
Cyclopentolate—Flushing—Melphalan—breast cancer	0.000347	0.00443	CcSEcCtD
Cyclopentolate—Agitation—Chlorambucil—breast cancer	0.000343	0.00438	CcSEcCtD
Cyclopentolate—Abdominal distension—Irinotecan—breast cancer	0.000339	0.00432	CcSEcCtD
Cyclopentolate—Conjunctivitis—Thiotepa—breast cancer	0.000338	0.00431	CcSEcCtD
Cyclopentolate—Paralysis—Doxorubicin—breast cancer	0.000333	0.00425	CcSEcCtD
Cyclopentolate—BCHE—endocrine gland—breast cancer	0.000331	0.0255	CbGeAlD
Cyclopentolate—Rash—Fulvestrant—breast cancer	0.000324	0.00413	CcSEcCtD
Cyclopentolate—Dermatitis—Fulvestrant—breast cancer	0.000324	0.00413	CcSEcCtD
Cyclopentolate—Convulsion—Chlorambucil—breast cancer	0.000324	0.00413	CcSEcCtD
Cyclopentolate—Rash—Toremifene—breast cancer	0.00032	0.00408	CcSEcCtD
Cyclopentolate—Dermatitis—Toremifene—breast cancer	0.000319	0.00407	CcSEcCtD
Cyclopentolate—Pruritus—Exemestane—breast cancer	0.000316	0.00403	CcSEcCtD
Cyclopentolate—Hallucination—Thiotepa—breast cancer	0.00031	0.00396	CcSEcCtD
Cyclopentolate—Vertigo—Vinblastine—breast cancer	0.000307	0.00392	CcSEcCtD
Cyclopentolate—Flushing—Vinorelbine—breast cancer	0.000303	0.00387	CcSEcCtD
Cyclopentolate—Drowsiness—Mitoxantrone—breast cancer	0.0003	0.00383	CcSEcCtD
Cyclopentolate—Vision blurred—Goserelin—breast cancer	0.000299	0.00382	CcSEcCtD
Cyclopentolate—Ataxia—Paclitaxel—breast cancer	0.000299	0.00381	CcSEcCtD
Cyclopentolate—Pruritus—Ixabepilone—breast cancer	0.000298	0.0038	CcSEcCtD
Cyclopentolate—Convulsion—Vinblastine—breast cancer	0.000296	0.00378	CcSEcCtD
Cyclopentolate—Gastroenteritis—Capecitabine—breast cancer	0.000294	0.00375	CcSEcCtD
Cyclopentolate—Conjunctivitis—Mitoxantrone—breast cancer	0.000292	0.00372	CcSEcCtD
Cyclopentolate—Vasodilation procedure—Epirubicin—breast cancer	0.000285	0.00363	CcSEcCtD
Cyclopentolate—Vasodilation—Epirubicin—breast cancer	0.000285	0.00363	CcSEcCtD
Cyclopentolate—Convulsion—Melphalan—breast cancer	0.000282	0.0036	CcSEcCtD
Cyclopentolate—Rash—Exemestane—breast cancer	0.000281	0.00359	CcSEcCtD
Cyclopentolate—Dermatitis—Exemestane—breast cancer	0.000281	0.00358	CcSEcCtD
Cyclopentolate—Pruritus—Anastrozole—breast cancer	0.00028	0.00358	CcSEcCtD
Cyclopentolate—Pruritus—Letrozole—breast cancer	0.00028	0.00358	CcSEcCtD
Cyclopentolate—Conjunctivitis—Fluorouracil—breast cancer	0.000279	0.00356	CcSEcCtD
Cyclopentolate—Dry mouth—Tamoxifen—breast cancer	0.000277	0.00353	CcSEcCtD
Cyclopentolate—Abdominal distension—Paclitaxel—breast cancer	0.000276	0.00352	CcSEcCtD
Cyclopentolate—Convulsion—Goserelin—breast cancer	0.000275	0.00351	CcSEcCtD
Cyclopentolate—Lacrimation increased—Epirubicin—breast cancer	0.000271	0.00346	CcSEcCtD
Cyclopentolate—Methylphenidate—CYP2D6—breast cancer	0.00027	0.0902	CrCbGaD
Cyclopentolate—Dexmethylphenidate—CYP2D6—breast cancer	0.00027	0.0902	CrCbGaD
Cyclopentolate—Venlafaxine—CYP2D6—breast cancer	0.000267	0.0891	CrCbGaD
Cyclopentolate—Rash—Ixabepilone—breast cancer	0.000265	0.00339	CcSEcCtD
Cyclopentolate—Dermatitis—Ixabepilone—breast cancer	0.000265	0.00338	CcSEcCtD
Cyclopentolate—Dry mouth—Goserelin—breast cancer	0.000264	0.00337	CcSEcCtD
Cyclopentolate—Vasodilation procedure—Doxorubicin—breast cancer	0.000263	0.00336	CcSEcCtD
Cyclopentolate—Vasodilation—Doxorubicin—breast cancer	0.000263	0.00336	CcSEcCtD
Cyclopentolate—Tachycardia—Melphalan—breast cancer	0.000259	0.00331	CcSEcCtD
Cyclopentolate—Vision blurred—Thiotepa—breast cancer	0.000256	0.00326	CcSEcCtD
Cyclopentolate—Vertigo—Vinorelbine—breast cancer	0.000255	0.00326	CcSEcCtD
Cyclopentolate—Coordination abnormal—Epirubicin—breast cancer	0.000255	0.00325	CcSEcCtD
Cyclopentolate—Ataxia—Docetaxel—breast cancer	0.000253	0.00323	CcSEcCtD
Cyclopentolate—Tachycardia—Goserelin—breast cancer	0.000253	0.00322	CcSEcCtD
Cyclopentolate—Lacrimation increased—Doxorubicin—breast cancer	0.000251	0.0032	CcSEcCtD
Cyclopentolate—Flushing—Irinotecan—breast cancer	0.00025	0.00319	CcSEcCtD
Cyclopentolate—Rash—Anastrozole—breast cancer	0.00025	0.00319	CcSEcCtD
Cyclopentolate—Rash—Letrozole—breast cancer	0.00025	0.00319	CcSEcCtD
Cyclopentolate—Dermatitis—Anastrozole—breast cancer	0.00025	0.00318	CcSEcCtD
Cyclopentolate—Dermatitis—Letrozole—breast cancer	0.00025	0.00318	CcSEcCtD
Cyclopentolate—Agitation—Thiotepa—breast cancer	0.00025	0.00318	CcSEcCtD
Cyclopentolate—Urinary retention—Capecitabine—breast cancer	0.000248	0.00316	CcSEcCtD
Cyclopentolate—Ataxia—Capecitabine—breast cancer	0.000245	0.00313	CcSEcCtD
Cyclopentolate—Coma—Methotrexate—breast cancer	0.000244	0.00311	CcSEcCtD
Cyclopentolate—Orphenadrine—SCN10A—breast cancer	0.000243	0.081	CrCbGaD
Cyclopentolate—Conjunctivitis—Paclitaxel—breast cancer	0.000238	0.00303	CcSEcCtD
Cyclopentolate—Rash—Idarubicin—breast cancer	0.000237	0.00303	CcSEcCtD
Cyclopentolate—Rash—Raloxifene—breast cancer	0.000237	0.00303	CcSEcCtD
Cyclopentolate—Dermatitis—Raloxifene—breast cancer	0.000237	0.00302	CcSEcCtD
Cyclopentolate—Dermatitis—Idarubicin—breast cancer	0.000237	0.00302	CcSEcCtD
Cyclopentolate—Coordination abnormal—Doxorubicin—breast cancer	0.000236	0.00301	CcSEcCtD
Cyclopentolate—Convulsion—Thiotepa—breast cancer	0.000235	0.003	CcSEcCtD
Cyclopentolate—Somnolence—Goserelin—breast cancer	0.00023	0.00294	CcSEcCtD
Cyclopentolate—Venlafaxine—CYP3A4—breast cancer	0.000229	0.0764	CrCbGaD
Cyclopentolate—BCHE—lymph node—breast cancer	0.000229	0.0176	CbGeAlD
Cyclopentolate—Coma—Epirubicin—breast cancer	0.000229	0.00291	CcSEcCtD
Cyclopentolate—Abdominal distension—Capecitabine—breast cancer	0.000227	0.00289	CcSEcCtD
Cyclopentolate—Tachycardia—Vinorelbine—breast cancer	0.000227	0.00289	CcSEcCtD
Cyclopentolate—Vision blurred—Mitoxantrone—breast cancer	0.000221	0.00282	CcSEcCtD
Cyclopentolate—Tachycardia—Thiotepa—breast cancer	0.000216	0.00276	CcSEcCtD
Cyclopentolate—Pruritus—Chlorambucil—breast cancer	0.000216	0.00275	CcSEcCtD
Cyclopentolate—Vision blurred—Fluorouracil—breast cancer	0.000212	0.0027	CcSEcCtD
Cyclopentolate—Coma—Doxorubicin—breast cancer	0.000211	0.0027	CcSEcCtD
Cyclopentolate—Vertigo—Irinotecan—breast cancer	0.000211	0.00269	CcSEcCtD
Cyclopentolate—Flushing—Paclitaxel—breast cancer	0.000204	0.0026	CcSEcCtD
Cyclopentolate—Convulsion—Mitoxantrone—breast cancer	0.000203	0.00259	CcSEcCtD
Cyclopentolate—Conjunctivitis—Docetaxel—breast cancer	0.000202	0.00257	CcSEcCtD
Cyclopentolate—Somnolence—Thiotepa—breast cancer	0.000197	0.00251	CcSEcCtD
Cyclopentolate—Conjunctivitis—Capecitabine—breast cancer	0.000195	0.00249	CcSEcCtD
Cyclopentolate—Convulsion—Fluorouracil—breast cancer	0.000195	0.00248	CcSEcCtD
Cyclopentolate—Pruritus—Tamoxifen—breast cancer	0.000192	0.00245	CcSEcCtD
Cyclopentolate—Venlafaxine—ABCB1—breast cancer	0.000191	0.0636	CrCbGaD
Cyclopentolate—Pruritus—Melphalan—breast cancer	0.000188	0.0024	CcSEcCtD
Cyclopentolate—Tachycardia—Mitoxantrone—breast cancer	0.000187	0.00238	CcSEcCtD
Cyclopentolate—Pruritus—Goserelin—breast cancer	0.000183	0.00234	CcSEcCtD
Cyclopentolate—Ataxia—Methotrexate—breast cancer	0.000182	0.00233	CcSEcCtD
Cyclopentolate—Vision blurred—Paclitaxel—breast cancer	0.00018	0.0023	CcSEcCtD
Cyclopentolate—Tremor—Paclitaxel—breast cancer	0.000179	0.00229	CcSEcCtD
Cyclopentolate—Tachycardia—Fluorouracil—breast cancer	0.000179	0.00228	CcSEcCtD
Cyclopentolate—Agitation—Paclitaxel—breast cancer	0.000176	0.00224	CcSEcCtD
Cyclopentolate—Flushing—Docetaxel—breast cancer	0.000173	0.0022	CcSEcCtD
Cyclopentolate—Vertigo—Paclitaxel—breast cancer	0.000172	0.00219	CcSEcCtD
Cyclopentolate—Rash—Tamoxifen—breast cancer	0.000171	0.00218	CcSEcCtD
Cyclopentolate—Dermatitis—Tamoxifen—breast cancer	0.000171	0.00218	CcSEcCtD
Cyclopentolate—Ataxia—Epirubicin—breast cancer	0.000171	0.00218	CcSEcCtD
Cyclopentolate—Somnolence—Mitoxantrone—breast cancer	0.00017	0.00217	CcSEcCtD
Cyclopentolate—Somnolence—Irinotecan—breast cancer	0.00017	0.00217	CcSEcCtD
Cyclopentolate—Rash—Melphalan—breast cancer	0.000167	0.00214	CcSEcCtD
Cyclopentolate—Flushing—Capecitabine—breast cancer	0.000167	0.00213	CcSEcCtD
Cyclopentolate—Dermatitis—Melphalan—breast cancer	0.000167	0.00213	CcSEcCtD
Cyclopentolate—Somnolence—Gemcitabine—breast cancer	0.000166	0.00211	CcSEcCtD
Cyclopentolate—Convulsion—Paclitaxel—breast cancer	0.000166	0.00211	CcSEcCtD
Cyclopentolate—Pruritus—Vinorelbine—breast cancer	0.000164	0.00209	CcSEcCtD
Cyclopentolate—Rash—Goserelin—breast cancer	0.000163	0.00208	CcSEcCtD
Cyclopentolate—Dermatitis—Goserelin—breast cancer	0.000163	0.00208	CcSEcCtD
Cyclopentolate—Somnolence—Fluorouracil—breast cancer	0.000163	0.00208	CcSEcCtD
Cyclopentolate—Dry mouth—Paclitaxel—breast cancer	0.000159	0.00203	CcSEcCtD
Cyclopentolate—Abdominal distension—Epirubicin—breast cancer	0.000158	0.00201	CcSEcCtD
Cyclopentolate—Ataxia—Doxorubicin—breast cancer	0.000158	0.00201	CcSEcCtD
Cyclopentolate—Pruritus—Thiotepa—breast cancer	0.000157	0.002	CcSEcCtD
Cyclopentolate—Tachycardia—Paclitaxel—breast cancer	0.000152	0.00194	CcSEcCtD
Cyclopentolate—Drowsiness—Methotrexate—breast cancer	0.00015	0.00191	CcSEcCtD
Cyclopentolate—Vision blurred—Capecitabine—breast cancer	0.000148	0.00189	CcSEcCtD
Cyclopentolate—Tremor—Capecitabine—breast cancer	0.000147	0.00188	CcSEcCtD
Cyclopentolate—Rash—Vinorelbine—breast cancer	0.000146	0.00187	CcSEcCtD
Cyclopentolate—Dermatitis—Vinorelbine—breast cancer	0.000146	0.00186	CcSEcCtD
Cyclopentolate—Abdominal distension—Doxorubicin—breast cancer	0.000146	0.00186	CcSEcCtD
Cyclopentolate—Conjunctivitis—Methotrexate—breast cancer	0.000145	0.00185	CcSEcCtD
Cyclopentolate—Vertigo—Capecitabine—breast cancer	0.000141	0.0018	CcSEcCtD
Cyclopentolate—Convulsion—Docetaxel—breast cancer	0.00014	0.00179	CcSEcCtD
Cyclopentolate—Drowsiness—Epirubicin—breast cancer	0.00014	0.00178	CcSEcCtD
Cyclopentolate—Rash—Thiotepa—breast cancer	0.00014	0.00178	CcSEcCtD
Cyclopentolate—Dermatitis—Thiotepa—breast cancer	0.00014	0.00178	CcSEcCtD
Cyclopentolate—Somnolence—Paclitaxel—breast cancer	0.000139	0.00177	CcSEcCtD
Cyclopentolate—Pethidine—CYP2D6—breast cancer	0.000137	0.0456	CrCbGaD
Cyclopentolate—Conjunctivitis—Epirubicin—breast cancer	0.000136	0.00173	CcSEcCtD
Cyclopentolate—Dry mouth—Docetaxel—breast cancer	0.000135	0.00172	CcSEcCtD
Cyclopentolate—Pruritus—Gemcitabine—breast cancer	0.000132	0.00168	CcSEcCtD
Cyclopentolate—Dry mouth—Capecitabine—breast cancer	0.000131	0.00167	CcSEcCtD
Cyclopentolate—Pruritus—Fluorouracil—breast cancer	0.00013	0.00165	CcSEcCtD
Cyclopentolate—Drowsiness—Doxorubicin—breast cancer	0.000129	0.00165	CcSEcCtD
Cyclopentolate—Tachycardia—Docetaxel—breast cancer	0.000129	0.00165	CcSEcCtD
Cyclopentolate—Conjunctivitis—Doxorubicin—breast cancer	0.000126	0.0016	CcSEcCtD
Cyclopentolate—Tachycardia—Capecitabine—breast cancer	0.000125	0.00159	CcSEcCtD
Cyclopentolate—Rash—Irinotecan—breast cancer	0.000121	0.00154	CcSEcCtD
Cyclopentolate—Rash—Mitoxantrone—breast cancer	0.000121	0.00154	CcSEcCtD
Cyclopentolate—Dermatitis—Irinotecan—breast cancer	0.000121	0.00154	CcSEcCtD
Cyclopentolate—Dermatitis—Mitoxantrone—breast cancer	0.000121	0.00154	CcSEcCtD
Cyclopentolate—Somnolence—Docetaxel—breast cancer	0.000118	0.0015	CcSEcCtD
Cyclopentolate—Rash—Gemcitabine—breast cancer	0.000118	0.0015	CcSEcCtD
Cyclopentolate—Dermatitis—Gemcitabine—breast cancer	0.000117	0.0015	CcSEcCtD
Cyclopentolate—Pethidine—CYP3A4—breast cancer	0.000117	0.0391	CrCbGaD
Cyclopentolate—Flushing—Epirubicin—breast cancer	0.000117	0.00149	CcSEcCtD
Cyclopentolate—Diphenhydramine—PTGS1—breast cancer	0.000116	0.0387	CrCbGaD
Cyclopentolate—Rash—Fluorouracil—breast cancer	0.000116	0.00147	CcSEcCtD
Cyclopentolate—Dermatitis—Fluorouracil—breast cancer	0.000115	0.00147	CcSEcCtD
Cyclopentolate—Pruritus—Paclitaxel—breast cancer	0.00011	0.00141	CcSEcCtD
Cyclopentolate—Vision blurred—Methotrexate—breast cancer	0.00011	0.0014	CcSEcCtD
Cyclopentolate—Flushing—Doxorubicin—breast cancer	0.000108	0.00138	CcSEcCtD
Cyclopentolate—Vertigo—Methotrexate—breast cancer	0.000105	0.00134	CcSEcCtD
Cyclopentolate—Vision blurred—Epirubicin—breast cancer	0.000103	0.00131	CcSEcCtD
Cyclopentolate—Pethidine—ALB—breast cancer	0.000102	0.0341	CrCbGaD
Cyclopentolate—Convulsion—Methotrexate—breast cancer	0.000101	0.00129	CcSEcCtD
Cyclopentolate—Agitation—Epirubicin—breast cancer	0.0001	0.00128	CcSEcCtD
Cyclopentolate—Rash—Paclitaxel—breast cancer	9.84e-05	0.00126	CcSEcCtD
Cyclopentolate—Dermatitis—Paclitaxel—breast cancer	9.83e-05	0.00125	CcSEcCtD
Cyclopentolate—Vertigo—Epirubicin—breast cancer	9.82e-05	0.00125	CcSEcCtD
Cyclopentolate—Vision blurred—Doxorubicin—breast cancer	9.54e-05	0.00122	CcSEcCtD
Cyclopentolate—Convulsion—Epirubicin—breast cancer	9.47e-05	0.00121	CcSEcCtD
Cyclopentolate—Pruritus—Docetaxel—breast cancer	9.36e-05	0.00119	CcSEcCtD
Cyclopentolate—Agitation—Doxorubicin—breast cancer	9.3e-05	0.00119	CcSEcCtD
Cyclopentolate—Dry mouth—Epirubicin—breast cancer	9.1e-05	0.00116	CcSEcCtD
Cyclopentolate—Vertigo—Doxorubicin—breast cancer	9.09e-05	0.00116	CcSEcCtD
Cyclopentolate—Pruritus—Capecitabine—breast cancer	9.06e-05	0.00116	CcSEcCtD
Cyclopentolate—Convulsion—Doxorubicin—breast cancer	8.77e-05	0.00112	CcSEcCtD
Cyclopentolate—Tachycardia—Epirubicin—breast cancer	8.71e-05	0.00111	CcSEcCtD
Cyclopentolate—Somnolence—Methotrexate—breast cancer	8.48e-05	0.00108	CcSEcCtD
Cyclopentolate—Dry mouth—Doxorubicin—breast cancer	8.42e-05	0.00107	CcSEcCtD
Cyclopentolate—Rash—Docetaxel—breast cancer	8.34e-05	0.00106	CcSEcCtD
Cyclopentolate—Dermatitis—Docetaxel—breast cancer	8.33e-05	0.00106	CcSEcCtD
Cyclopentolate—Rash—Capecitabine—breast cancer	8.08e-05	0.00103	CcSEcCtD
Cyclopentolate—Dermatitis—Capecitabine—breast cancer	8.07e-05	0.00103	CcSEcCtD
Cyclopentolate—Tachycardia—Doxorubicin—breast cancer	8.06e-05	0.00103	CcSEcCtD
Cyclopentolate—Somnolence—Epirubicin—breast cancer	7.93e-05	0.00101	CcSEcCtD
Cyclopentolate—Diphenhydramine—CYP2D6—breast cancer	7.89e-05	0.0263	CrCbGaD
Cyclopentolate—Somnolence—Doxorubicin—breast cancer	7.34e-05	0.000936	CcSEcCtD
Cyclopentolate—Pruritus—Methotrexate—breast cancer	6.75e-05	0.00086	CcSEcCtD
Cyclopentolate—Orphenadrine—CYP3A4—breast cancer	6.4e-05	0.0214	CrCbGaD
Cyclopentolate—Pruritus—Epirubicin—breast cancer	6.31e-05	0.000805	CcSEcCtD
Cyclopentolate—Rash—Methotrexate—breast cancer	6.01e-05	0.000767	CcSEcCtD
Cyclopentolate—Dermatitis—Methotrexate—breast cancer	6.01e-05	0.000766	CcSEcCtD
Cyclopentolate—Pruritus—Doxorubicin—breast cancer	5.84e-05	0.000745	CcSEcCtD
Cyclopentolate—Rash—Epirubicin—breast cancer	5.63e-05	0.000718	CcSEcCtD
Cyclopentolate—Dermatitis—Epirubicin—breast cancer	5.62e-05	0.000717	CcSEcCtD
Cyclopentolate—Rash—Doxorubicin—breast cancer	5.21e-05	0.000664	CcSEcCtD
Cyclopentolate—Dermatitis—Doxorubicin—breast cancer	5.2e-05	0.000663	CcSEcCtD
Cyclopentolate—BCHE—Metabolism—MTHFR—breast cancer	9.76e-06	0.000263	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—JAG1—breast cancer	9.75e-06	0.000263	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—NOTCH3—breast cancer	9.74e-06	0.000263	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—PARP1—breast cancer	9.74e-06	0.000263	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—PARP1—breast cancer	9.71e-06	0.000262	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—NOTCH3—breast cancer	9.71e-06	0.000262	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CALCA—breast cancer	9.63e-06	0.000259	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CALCA—breast cancer	9.59e-06	0.000258	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—RPS6—breast cancer	9.51e-06	0.000256	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—RPS6—breast cancer	9.48e-06	0.000255	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—FGF4—breast cancer	9.44e-06	0.000254	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—FGF4—breast cancer	9.41e-06	0.000253	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CXCL12—breast cancer	9.4e-06	0.000253	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CXCR4—breast cancer	9.4e-06	0.000253	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CXCL12—breast cancer	9.37e-06	0.000252	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CXCR4—breast cancer	9.37e-06	0.000252	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—COMT—breast cancer	9.29e-06	0.00025	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—GSTP1—breast cancer	9.24e-06	0.000249	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—PAK1—breast cancer	9.23e-06	0.000249	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—PAK1—breast cancer	9.2e-06	0.000248	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—HMOX1—breast cancer	9.12e-06	0.000246	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—ITPR1—breast cancer	9.09e-06	0.000245	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—TCF7L2—breast cancer	9.07e-06	0.000244	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—TCF7L2—breast cancer	9.04e-06	0.000243	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—AKT2—breast cancer	9.02e-06	0.000243	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—CAV1—breast cancer	9e-06	0.000243	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—AKT2—breast cancer	8.99e-06	0.000242	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—PIK3CG—breast cancer	8.96e-06	0.000241	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—PIK3CG—breast cancer	8.93e-06	0.00024	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—ABCB1—breast cancer	8.75e-06	0.000236	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—NOTCH2—breast cancer	8.74e-06	0.000235	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—HSP90AA1—breast cancer	8.74e-06	0.000235	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—HSP90AA1—breast cancer	8.71e-06	0.000235	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—NOTCH2—breast cancer	8.71e-06	0.000235	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—PIK3CD—breast cancer	8.67e-06	0.000234	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—PIK3CD—breast cancer	8.64e-06	0.000233	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	8.6e-06	0.000232	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—TYMS—breast cancer	8.59e-06	0.000231	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—PRL—breast cancer	8.5e-06	0.000229	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—AGTR1—breast cancer	8.5e-06	0.000229	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—NCOR1—breast cancer	8.49e-06	0.000229	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—PLA2G4A—breast cancer	8.49e-06	0.000229	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—GSTM1—breast cancer	8.49e-06	0.000229	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—AGTR1—breast cancer	8.48e-06	0.000228	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—PRL—breast cancer	8.48e-06	0.000228	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—STK11—breast cancer	8.38e-06	0.000226	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—ADAM10—breast cancer	8.38e-06	0.000226	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—STK11—breast cancer	8.35e-06	0.000225	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—ADAM10—breast cancer	8.35e-06	0.000225	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—PLG—breast cancer	8.29e-06	0.000223	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—PLG—breast cancer	8.26e-06	0.000222	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—PIK3CG—breast cancer	8.2e-06	0.000221	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—AKT2—breast cancer	8.19e-06	0.000221	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—AKT2—breast cancer	8.17e-06	0.00022	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—FGF10—breast cancer	8.15e-06	0.00022	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—GPX1—breast cancer	8.13e-06	0.000219	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—FGF10—breast cancer	8.13e-06	0.000219	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—CYP1A1—breast cancer	8.05e-06	0.000217	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—ERCC2—breast cancer	7.99e-06	0.000215	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—PIK3CD—breast cancer	7.87e-06	0.000212	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—PDGFA—breast cancer	7.87e-06	0.000212	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—PIK3CD—breast cancer	7.85e-06	0.000211	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—PDGFA—breast cancer	7.84e-06	0.000211	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—TGFBR2—breast cancer	7.75e-06	0.000209	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—TGFBR2—breast cancer	7.73e-06	0.000208	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—ITPR1—breast cancer	7.63e-06	0.000206	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—ITPR1—breast cancer	7.6e-06	0.000205	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—ERBB4—breast cancer	7.58e-06	0.000204	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—STAT5A—breast cancer	7.58e-06	0.000204	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—MMP3—breast cancer	7.58e-06	0.000204	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—PIK3CB—breast cancer	7.56e-06	0.000204	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—STAT5A—breast cancer	7.55e-06	0.000203	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—ERBB4—breast cancer	7.55e-06	0.000203	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—MMP3—breast cancer	7.55e-06	0.000203	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—PIK3CB—breast cancer	7.53e-06	0.000203	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—MTHFR—breast cancer	7.51e-06	0.000202	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—SMAD4—breast cancer	7.34e-06	0.000198	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—SMAD4—breast cancer	7.32e-06	0.000197	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—IGF1R—breast cancer	7.29e-06	0.000197	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—IGF1R—breast cancer	7.27e-06	0.000196	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—CXCL8—breast cancer	7.26e-06	0.000196	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—CXCL8—breast cancer	7.24e-06	0.000195	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—PIK3CD—breast cancer	7.21e-06	0.000194	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—HES1—breast cancer	7.17e-06	0.000193	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—HES1—breast cancer	7.14e-06	0.000192	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—PLA2G4A—breast cancer	7.12e-06	0.000192	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—NCOR1—breast cancer	7.12e-06	0.000192	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—ALB—breast cancer	7.12e-06	0.000192	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—NCOR1—breast cancer	7.1e-06	0.000191	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—PLA2G4A—breast cancer	7.1e-06	0.000191	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CSF2—breast cancer	7.04e-06	0.00019	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—FGF1—breast cancer	7.04e-06	0.00019	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—RAF1—breast cancer	7.03e-06	0.000189	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CSF2—breast cancer	7.02e-06	0.000189	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—FGF1—breast cancer	7.02e-06	0.000189	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—RAF1—breast cancer	7.01e-06	0.000189	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—NRG1—breast cancer	6.99e-06	0.000188	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—NRG1—breast cancer	6.97e-06	0.000188	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—H2AFX—breast cancer	6.94e-06	0.000187	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—IL2—breast cancer	6.94e-06	0.000187	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—CAV1—breast cancer	6.92e-06	0.000187	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—H2AFX—breast cancer	6.92e-06	0.000186	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—IL2—breast cancer	6.92e-06	0.000186	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—E2F1—breast cancer	6.89e-06	0.000186	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—E2F1—breast cancer	6.87e-06	0.000185	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—PIK3CB—breast cancer	6.86e-06	0.000185	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—PIK3CB—breast cancer	6.84e-06	0.000184	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—NOS3—breast cancer	6.81e-06	0.000183	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—SPP1—breast cancer	6.62e-06	0.000178	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—SPP1—breast cancer	6.6e-06	0.000178	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—CXCL8—breast cancer	6.59e-06	0.000178	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—CXCL8—breast cancer	6.57e-06	0.000177	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—ERBB3—breast cancer	6.55e-06	0.000176	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—FGFR2—breast cancer	6.54e-06	0.000176	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—ERBB3—breast cancer	6.53e-06	0.000176	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—FGFR2—breast cancer	6.52e-06	0.000176	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—PIK3CG—breast cancer	6.31e-06	0.00017	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—IL2—breast cancer	6.3e-06	0.00017	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—PIK3CB—breast cancer	6.28e-06	0.000169	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—IL2—breast cancer	6.28e-06	0.000169	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—TERT—breast cancer	6.28e-06	0.000169	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—TERT—breast cancer	6.26e-06	0.000169	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—PTGS2—breast cancer	6.23e-06	0.000168	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—FGFR1—breast cancer	6.1e-06	0.000164	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—FGFR1—breast cancer	6.08e-06	0.000164	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—HIF1A—breast cancer	6.01e-06	0.000162	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—HIF1A—breast cancer	5.99e-06	0.000161	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—LEP—breast cancer	5.86e-06	0.000158	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—LEP—breast cancer	5.84e-06	0.000157	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CAV1—breast cancer	5.81e-06	0.000156	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CAV1—breast cancer	5.79e-06	0.000156	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—KDR—breast cancer	5.74e-06	0.000155	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—KDR—breast cancer	5.72e-06	0.000154	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—ESR1—breast cancer	5.6e-06	0.000151	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—ESR1—breast cancer	5.58e-06	0.00015	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—PIK3CD—breast cancer	5.54e-06	0.000149	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—FN1—breast cancer	5.53e-06	0.000149	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—FN1—breast cancer	5.51e-06	0.000148	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—ALB—breast cancer	5.47e-06	0.000147	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—NFKBIA—breast cancer	5.46e-06	0.000147	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—NFKBIA—breast cancer	5.45e-06	0.000147	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—PTEN—breast cancer	5.43e-06	0.000146	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—NOTCH1—breast cancer	5.41e-06	0.000146	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—NOTCH1—breast cancer	5.39e-06	0.000145	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—APC—breast cancer	5.29e-06	0.000143	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—PIK3CG—breast cancer	5.29e-06	0.000143	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—KIT—breast cancer	5.29e-06	0.000143	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—PIK3CG—breast cancer	5.27e-06	0.000142	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—APC—breast cancer	5.27e-06	0.000142	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—KIT—breast cancer	5.27e-06	0.000142	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—NOS3—breast cancer	5.24e-06	0.000141	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—EGF—breast cancer	5.23e-06	0.000141	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—EGF—breast cancer	5.21e-06	0.00014	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—MAPK3—breast cancer	5.07e-06	0.000136	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—MAPK3—breast cancer	5.05e-06	0.000136	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—BRAF—breast cancer	4.97e-06	0.000134	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—BRAF—breast cancer	4.96e-06	0.000134	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—IGF1—breast cancer	4.84e-06	0.00013	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—AKT2—breast cancer	4.84e-06	0.00013	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—PIK3CB—breast cancer	4.83e-06	0.00013	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—IGF1—breast cancer	4.83e-06	0.00013	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—AKT2—breast cancer	4.83e-06	0.00013	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—EGFR—breast cancer	4.82e-06	0.00013	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—EGFR—breast cancer	4.8e-06	0.000129	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—PTGS2—breast cancer	4.79e-06	0.000129	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—PIK3CD—breast cancer	4.65e-06	0.000125	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—PIK3CD—breast cancer	4.64e-06	0.000125	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—PIK3CA—breast cancer	4.61e-06	0.000124	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—SERPINE1—breast cancer	4.6e-06	0.000124	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—PIK3CA—breast cancer	4.59e-06	0.000124	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—SERPINE1—breast cancer	4.59e-06	0.000124	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—KRAS—breast cancer	4.55e-06	0.000123	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—KRAS—breast cancer	4.54e-06	0.000122	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—NOS3—breast cancer	4.39e-06	0.000118	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—NOS3—breast cancer	4.38e-06	0.000118	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—PIK3CA—breast cancer	4.18e-06	0.000113	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—PTEN—breast cancer	4.18e-06	0.000112	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—PIK3CA—breast cancer	4.17e-06	0.000112	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—MDM2—breast cancer	4.17e-06	0.000112	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—MDM2—breast cancer	4.15e-06	0.000112	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—RAF1—breast cancer	4.15e-06	0.000112	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—RAF1—breast cancer	4.14e-06	0.000111	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—RELA—breast cancer	4.13e-06	0.000111	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—RELA—breast cancer	4.12e-06	0.000111	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—ERBB2—breast cancer	4.11e-06	0.000111	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—ERBB2—breast cancer	4.09e-06	0.00011	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—PIK3CB—breast cancer	4.05e-06	0.000109	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—MTOR—breast cancer	4.05e-06	0.000109	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—MTOR—breast cancer	4.04e-06	0.000109	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—PIK3CB—breast cancer	4.04e-06	0.000109	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CXCL8—breast cancer	3.9e-06	0.000105	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CXCL8—breast cancer	3.88e-06	0.000105	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—HRAS—breast cancer	3.87e-06	0.000104	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—HRAS—breast cancer	3.86e-06	0.000104	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—PIK3CA—breast cancer	3.83e-06	0.000103	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CDKN1B—breast cancer	3.8e-06	0.000102	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CDKN1B—breast cancer	3.79e-06	0.000102	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—AKT1—breast cancer	3.76e-06	0.000101	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—AKT1—breast cancer	3.75e-06	0.000101	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CASP3—breast cancer	3.73e-06	0.0001	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—IL2—breast cancer	3.72e-06	0.0001	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CASP3—breast cancer	3.72e-06	0.0001	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—IL2—breast cancer	3.71e-06	0.0001	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—IL6—breast cancer	3.7e-06	9.98e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—IL6—breast cancer	3.69e-06	9.95e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CCND1—breast cancer	3.63e-06	9.78e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—JUN—breast cancer	3.62e-06	9.76e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CCND1—breast cancer	3.62e-06	9.75e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—JUN—breast cancer	3.61e-06	9.73e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CTNNB1—breast cancer	3.59e-06	9.68e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CTNNB1—breast cancer	3.58e-06	9.65e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—MMP9—breast cancer	3.52e-06	9.49e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—MMP9—breast cancer	3.51e-06	9.46e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CDKN1A—breast cancer	3.51e-06	9.46e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—PTEN—breast cancer	3.5e-06	9.44e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CDKN1A—breast cancer	3.5e-06	9.43e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—PTEN—breast cancer	3.49e-06	9.41e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—MAPK8—breast cancer	3.43e-06	9.23e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—AKT1—breast cancer	3.42e-06	9.21e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—MAPK8—breast cancer	3.42e-06	9.2e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—AKT1—breast cancer	3.41e-06	9.18e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—SRC—breast cancer	3.25e-06	8.75e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—SRC—breast cancer	3.24e-06	8.72e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—VEGFA—breast cancer	3.16e-06	8.52e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—VEGFA—breast cancer	3.15e-06	8.5e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—STAT3—breast cancer	3.13e-06	8.44e-05	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—AKT1—breast cancer	3.13e-06	8.43e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—STAT3—breast cancer	3.12e-06	8.41e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—MAPK3—breast cancer	2.99e-06	8.06e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—MAPK3—breast cancer	2.98e-06	8.04e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—PIK3CA—breast cancer	2.95e-06	7.94e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—MYC—breast cancer	2.91e-06	7.84e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—TGFB1—breast cancer	2.9e-06	7.82e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—MYC—breast cancer	2.9e-06	7.82e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—TGFB1—breast cancer	2.89e-06	7.8e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—EGFR—breast cancer	2.85e-06	7.67e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—EGFR—breast cancer	2.84e-06	7.65e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—KRAS—breast cancer	2.69e-06	7.25e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—KRAS—breast cancer	2.68e-06	7.22e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—PIK3CA—breast cancer	2.47e-06	6.66e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—PIK3CA—breast cancer	2.46e-06	6.64e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—AKT1—breast cancer	2.41e-06	6.48e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—TP53—breast cancer	2.39e-06	6.44e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—TP53—breast cancer	2.38e-06	6.42e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—HRAS—breast cancer	2.29e-06	6.16e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—HRAS—breast cancer	2.28e-06	6.14e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—IL6—breast cancer	2.19e-06	5.89e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—IL6—breast cancer	2.18e-06	5.88e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—AKT1—breast cancer	2.02e-06	5.44e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—AKT1—breast cancer	2.01e-06	5.42e-05	CbGpPWpGaD
